In addition to the increased recruitment signals of immune effector cells, we have also observed that SGT-53 treatment resulted in a shift in macrophage polarization away from the immunosuppressive M2 phenotype and toward tumor-inhibiting M1 phenotype. The gene discussed is SGTA; the disease is neoplasm.